James Miln, serving as the Chief Financial Officer for Xometry, Inc. (NASDAQ: XMTR), has finalized the sale of Class A Common Stock valued at approximately $119,529. The transactions took place on May 11, 2026, with the shares being sold at weighted average prices falling within a range of $79.4511 to $80.0063 per share.
Transaction Specifics
The divestment was comprised of two distinct selling events. The initial portion of the sale involved 864 shares, which were traded at a weighted average price of $79.4511. These specific transactions occurred at varying price points, ranging from a low of $78.84 to a high of $79.78 per share. The second component of the sale consisted of 636 shares, yielding a weighted average price of $80.0063. The pricing for these individual transactions fluctuated between $79.84 and $80.47.
Notably, these trades were not discretionary immediate sales but were carried out automatically under the framework of a Rule 10b5-1 trading plan. This plan had been established by Mr. Miln at least 90 days prior to the execution date. Following the completion of these sales, Mr. Miln maintains a direct ownership stake in Xometry consisting of 184,523 shares of Class A Common Stock.
Market Context and Financial Performance
The timing of this insider selling coincides with a period of intense price appreciation for XMTR. Over the last twelve months, Xometry shares have surged by 182%. As of the recent reporting, the stock is trading at $86.19, which sits close to its 52-week high of $89.79. Despite this momentum, valuation analysis indicates that the stock appears overvalued when measured against its Fair Value assessment.
This capital activity follows a period of robust financial reporting from Xometry. For the first quarter of 2026, the company reported earnings that outperformed market consensus. Specifically, Xometry posted earnings per share (EPS) of $0.12, surpassing the anticipated figure of $0.10. Additionally, revenue for the quarter reached $205 million, which was higher than the projected $188.47 million. While these results signaled a strong start to the fiscal year and were viewed positively by the investment community, no specific changes in analyst ratings were noted.
Key Analysis Points
- Insider Liquidation via Pre-planned Schedules: The use of a Rule 10b5-1 plan indicates that the sale was scheduled well in advance, providing a structured exit for the CFO regardless of immediate market fluctuations.
- Price Momentum vs. Valuation Discrepancy: While Xometry has demonstrated massive growth with a 182% annual increase, there is a notable tension between the current trading price and the stock's calculated fair value.
- Strong Operational Execution: The company's ability to beat both EPS and revenue estimates in Q1 2026 demonstrates strong fundamental performance in the short term.
Market Impacts & Sector Considerations
The activity within Xometry can influence sentiment within the technology and industrial services sectors, as executive movements often signal internal perspectives on valuation. The recent earnings beat suggests strength in the company's specific market segment, potentially impacting broader industrial growth expectations.
Risks and Uncertainties
- Valuation Risk: With the stock trading near its 52-week high and appearing overvalued based on fair value assessments, there is a risk of price correction if market sentiment shifts.
- Growth Sustainability: While Q1 results exceeded forecasts, the long-term ability to maintain this level of outperformance relative to projections remains an ongoing variable for investors.